Abeona Therapeutics (ABEO) Revenue (2011 - 2026)

Abeona Therapeutics (ABEO) posted quarterly Revenue of $8.7 million for Q1 2026, up 60.89% quarter-over-quarter from $5.4 million in Q4 2025.

Abeona Therapeutics (ABEO) Revenue (2011 - 2026) Analysis & Trends

Abeona Therapeutics' Revenue history runs 13 years deep, the most recent figure standing at $8.7 million for Q1 2026.

In Q1 2026, Revenue changed N/A year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at $14.5 million (changed N/A YoY), while the FY2025 annual figure was $5.8 million, changed N/A from the prior year.
Revenue for Q1 2026 stood at $8.7 million, up from $5.4 million in the prior quarter.
The five-year high for Revenue was $8.7 million in Q1 2026, with the low at $68000.0 in Q4 2022.
The 4-year median for Revenue is $1.0 million (2022), against an average of $2.8 million.
Peak annual rise in Revenue reached 250.0% in 2023, while the deepest fall reached 250.0% in 2023.
Abeona Therapeutics' Revenue stood at $68000.0 in 2022, then jumped by 5047.06% to $3.5 million in 2023, then jumped by 54.86% to $5.4 million in 2025, then jumped by 60.89% to $8.7 million in 2026.
Business Quant data shows ABEO's Revenue at $8.7 million in Q1 2026, $5.4 million in Q4 2025, and $400000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	3.33 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	4.29 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	1.56 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1.71 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	3,001.92
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	674.14 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	1.29 Bn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	425.49 Mn
10	Abeona Therapeutics	342.78 Mn	195.96 Mn	7.20 Mn	11.38 Mn

Download Data